Medtech initiative framework
This initiative in the field of Biosciences-Health is part of one of the three strategic priorities of the RIS3 Euskadi strategy, and the Health Research and Innovation Strategy 2020 (EIIS 2020), and represents the opportunity to take advantage of the driving effect of the Health System to complement the scientific-technological and business capacities of the Basque Country in favor of health, the improvement of the performance of the health system itself, and the generation of wealth. For this, it is necessary to promote the collaboration of the Health System with the Basque business and scientific-technological system.
In this sense, the EIIS 2020 includes in its first Strategic Axis (Impact) the development of open innovation programs such as Innosasun, which facilitates the interaction between the health system and companies, and is also considered one of the “Initiatives Strategies ”of the Biosciences-Health area of RIS3. This program, in which the entire health system participates and which is coordinated by BIOEF, aims to offer personalized support to companies and scientific-technological agents in the development of products and services with potential application in health, turning the Health System into a partner of reference. Among others, Innosasun offers the operation of the healthcare system as a test bench or living lab in a real environment for demonstration, validation and / or cost-effectiveness studies of medical devices and technologies.
This activity is precisely the object of the MEDTECH initiative promoted -through the Innovation Fund- by Lehendakaritza and the Department of Health of the Basque Government.